rs1556865202
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001111125.3(IQSEC2):āc.746G>Cā(p.Gly249Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 112,359 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001111125.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IQSEC2 | NM_001111125.3 | c.746G>C | p.Gly249Ala | missense_variant | 3/15 | ENST00000642864.1 | NP_001104595.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IQSEC2 | ENST00000642864.1 | c.746G>C | p.Gly249Ala | missense_variant | 3/15 | NM_001111125.3 | ENSP00000495726 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112359Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34529
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000189 AC: 2AN: 1056574Hom.: 0 Cov.: 30 AF XY: 0.00000297 AC XY: 1AN XY: 336518
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112359Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34529
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2022 | The c.746G>C (p.G249A) alteration is located in exon 3 (coding exon 3) of the IQSEC2 gene. This alteration results from a G to C substitution at nucleotide position 746, causing the glycine (G) at amino acid position 249 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Intellectual disability, X-linked 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 249 of the IQSEC2 protein (p.Gly249Ala). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with IQSEC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 521369). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt IQSEC2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
IQSEC2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 23, 2024 | The IQSEC2 c.746G>C variant is predicted to result in the amino acid substitution p.Gly249Ala. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at